Tools to Improve Medication Continuity in Adolescents With ADHD

Cincinnati Children's Hospital Medical Center

Status: Completed

Conditions: Attention Deficit Hyperactivity Disorder

Treatments: Other: Mehealth for ADHD software with medication continuity tools; Other: Mehealth for ADHD software without medication continuity tools

Study type: Interventional

Funder types: Other

Identifiers

NCT04173000

2019-0172

Details and patient eligibility

About

Medication is an efficacious treatment strategy for adolescents with attention-deficit/hyperactivity disorder (ADHD), however use significantly declines during adolescence when the consequences of ADHD are most severe (e.g. dropping out of school, delinquency, etc.). The Unified Theory of Behavior Change (UTBC) has been proposed as a conceptual model to explain the mechanism underlying ADHD medication adherence and to guide the development of interventions to improve the continuity of treatment. The UTBC is a well-established and empirically tested model that identifies factors that influence an individual's intention to perform a behavior as well as factors that influence whether a behavior is actually carried out. Indeed, the research team's preliminary data support the relevance of pre-intention factors and implementation factors for medication continuity among adolescents with ADHD. Currently, no evidence-based interventions target medication continuity for adolescents with ADHD. The objective of this study is to test a multi-component intervention that systematically identifies and targets aspects of the UTBC model most relevant for each adolescent with poor ADHD medication continuity. The central hypothesis is that the tailored intervention will support ADHD medication continuity. The study will conduct an open label trial among adolescents with poor medication continuity to test whether the intervention engages the mechanism underlying medication continuity and improves outcomes.

Enrollment: 16 patients

Sex: All

Ages: 11 to 15 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• First prescribed ADHD medicine more than one year prior to enrollment
• Registered on myADHDportal.com at practice participating in study
• Filled at least one prescription for a stimulant medication in the past year

Exclusion criteria

• More than 80% of days covered with medicine over past one year
• Poor understanding level: The participant and parent cannot understand or follow instructions given in the study.

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

16 participants in 1 patient group

Intervention

Experimental group

Description:

All adolescent/parent dyads enrolled at each practice will have access to the meHealth for ADHD software without medication continuity tools prior to being given access to the medication continuity tools.

Treatment:

Other: Mehealth for ADHD software without medication continuity tools

Other: Mehealth for ADHD software with medication continuity tools